GB124009A
(en)
|
1918-01-12 |
1919-03-12 |
Walter Edward Kimber |
Improvements in and connected with the Manufacture of Tools for Turning, Planing, Boring and similar purposes.
|
GB124010A
(en)
|
1919-01-10 |
1919-03-20 |
Rene Emile Dior |
Improved Process for the Manufacture of Synthetic Resins.
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
GB1381872A
(en)
|
1971-06-22 |
1975-01-29 |
Fisons Ltd |
Pharmaceutical compositions for inhalation
|
NL7304113A
(no)
|
1972-03-25 |
1973-09-27 |
|
|
GB2064336B
(en)
|
1979-12-06 |
1984-03-14 |
Glaxo Group Ltd |
Device for dispensing medicaments
|
DE3274065D1
(de)
|
1981-07-08 |
1986-12-11 |
Draco Ab |
Powder inhalator
|
ES286422Y
(es)
|
1982-10-08 |
1986-09-16 |
Glaxo Group Limited |
Dispositivo para administrar medicamentos a pacientes
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
GB2169265B
(en)
|
1982-10-08 |
1987-08-12 |
Glaxo Group Ltd |
Pack for medicament
|
AU591152B2
(en)
|
1985-07-30 |
1989-11-30 |
Glaxo Group Limited |
Devices for administering medicaments to patients
|
GB8530365D0
(en)
|
1985-12-10 |
1986-01-22 |
Univ Bath |
Manufacture of moulded products
|
IT1204826B
(it)
|
1986-03-04 |
1989-03-10 |
Chiesi Farma Spa |
Composizioni farmaceutiche per inalazione
|
CA1329526C
(en)
|
1987-08-20 |
1994-05-17 |
Hiroshi Ikura |
Powdery medicine applicator device
|
US4994276A
(en)
|
1988-09-19 |
1991-02-19 |
Edward Mendell Co., Inc. |
Directly compressible sustained release excipient
|
GB8820353D0
(en)
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
US5135757A
(en)
|
1988-09-19 |
1992-08-04 |
Edward Mendell Co., Inc. |
Compressible sustained release solid dosage forms
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
UA26230A
(uk)
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
SK280967B6
(sk)
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
FR2660634B1
(fr)
|
1990-04-06 |
1992-10-16 |
Airsec Ind Sa |
Conditionnement pour produits necessitant l'usage d'un agent deshydratant.
|
JPH0471560A
(ja)
|
1990-07-10 |
1992-03-06 |
Mect Corp |
包装体
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
DE4140689B4
(de)
|
1991-12-10 |
2007-11-22 |
Boehringer Ingelheim Kg |
Inhalationspulver und Verfahren zu ihrer Herstellung
|
ES2177544T3
(es)
|
1992-06-12 |
2002-12-16 |
Teijin Ltd |
Polvo ultrafinno para inhalar y metodo para su preparacion.
|
CA2115444C
(en)
|
1992-06-12 |
2000-10-03 |
Yuji Makino |
Preparation for intratracheobronchial administration
|
GB2269992A
(en)
|
1992-08-14 |
1994-03-02 |
Rh Ne Poulenc Rorer Limited |
Powder inhalation formulations
|
AU670627B2
(en)
|
1992-09-09 |
1996-07-25 |
Fisons Plc |
Pharmaceutical packaging
|
SE9203743D0
(sv)
|
1992-12-11 |
1992-12-11 |
Astra Ab |
Efficient use
|
DE69323897T2
(de)
|
1992-12-18 |
1999-11-04 |
Schering Corp |
Inhalator für pulverförmige medikamente
|
US5441060A
(en)
|
1993-02-08 |
1995-08-15 |
Duke University |
Dry powder delivery system
|
AU679511B2
(en)
|
1993-03-17 |
1997-07-03 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
US5730785A
(en)
|
1993-04-01 |
1998-03-24 |
Multisorb Technologies, Inc. |
Desiccant canister for desiccants and other particulate material
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
IS1796B
(is)
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
DE4323636A1
(de)
|
1993-07-15 |
1995-01-19 |
Hoechst Ag |
Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US5503662A
(en)
|
1994-03-29 |
1996-04-02 |
Multiform Desiccants, Inc. |
Canister with porous plastic ends
|
FI95441C
(fi)
|
1994-05-31 |
1996-02-12 |
Leiras Oy |
Inhalointilaitteen lääkeainekammio
|
US6156231A
(en)
|
1994-09-08 |
2000-12-05 |
Multisorb Technologies, Inc. |
Oxygen absorbing composition with cover layer
|
US5641425A
(en)
|
1994-09-08 |
1997-06-24 |
Multiform Desiccants, Inc. |
Oxygen absorbing composition
|
SA95160463B1
(ar)
|
1994-12-22 |
2005-10-04 |
استرا أكتيبولاج |
مساحيق للاستنشاق
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US6279736B1
(en)
|
1995-04-19 |
2001-08-28 |
Capitol Specialty Plastics, Inc. |
Barrier pack having an absorbing agent applied to the interior of the pack
|
KR19990007916A
(ko)
|
1995-04-19 |
1999-01-25 |
로버트 아브람스 |
밀폐 용기에 포함된 건조 물질
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
GB9700226D0
(en)
|
1997-01-08 |
1997-02-26 |
Glaxo Group Ltd |
Inhalation device
|
US6103141A
(en)
|
1997-01-23 |
2000-08-15 |
Multisorb Technologies, Inc. |
Desiccant deposit
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6153322A
(en)
|
1997-03-14 |
2000-11-28 |
Lee; T. Randall |
Methods for making fluorinated surface modifying agents, methods of using same and products made using same
|
US5985415A
(en)
|
1997-11-17 |
1999-11-16 |
Reconnx, Inc. |
Finger joint architecture for wood products, and method and apparatus for formation thereof
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
AU2577599A
(en)
|
1998-02-05 |
1999-08-23 |
Design Technology And Innovation Limited |
Water purification apparatus
|
EP1073417B1
(en)
|
1998-04-18 |
2002-12-04 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US20070212422A1
(en)
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
EP2266548B1
(de)
|
1998-11-13 |
2020-05-20 |
Jagotec AG |
Trockenpulver zur inhalation
|
GB9827145D0
(en)
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
US6315112B1
(en)
|
1998-12-18 |
2001-11-13 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6390291B1
(en)
|
1998-12-18 |
2002-05-21 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6352152B1
(en)
|
1998-12-18 |
2002-03-05 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6119853A
(en)
|
1998-12-18 |
2000-09-19 |
Glaxo Wellcome Inc. |
Method and package for storing a pressurized container containing a drug
|
IT1309592B1
(it)
|
1999-03-05 |
2002-01-24 |
Chiesi Farma Spa |
Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
|
SK286981B6
(sk)
|
1999-03-05 |
2009-08-06 |
Chiesi Farmaceutici S.P.A. |
Prášok na použitie v inhalátore na suché prášky, nosič na tento prášok a spôsob výroby prášku
|
USD440874S1
(en)
|
1999-07-29 |
2001-04-24 |
The Gillette Company |
Container
|
HUP0203626A2
(en)
|
1999-10-11 |
2003-02-28 |
Ml Lab Plc |
Medicament delivery device with moisture resistant coating
|
DE19957802A1
(de)
|
1999-12-01 |
2001-06-07 |
Trw Repa Gmbh |
Gurtaufrollersystem
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
AU2001252350A1
(en)
|
2000-04-13 |
2001-10-30 |
Innovata Biomed Limited |
Medicaments for treating respiratory disorders comprising formoterol and fluticasone
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
AU2001264594A1
(en)
|
2000-05-15 |
2001-11-26 |
Glaxo Group Limited |
Aerosol mdi overcap containing desiccant
|
GB0015043D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2001270074A1
(en)
|
2000-06-22 |
2002-01-02 |
Glaxo Group Limited |
Method and package for storing a pressurized container containing a drug
|
AR032471A1
(es)
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
GB0019172D0
(en)
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
DE10056855A1
(de)
|
2000-11-16 |
2002-05-29 |
Lohmann Therapie Syst Lts |
Verbundlaminat mit Sauerstoff und Feuchtigkeit absorbierender Schicht und Verfahren zu seiner Herstellung
|
DK2283817T3
(en)
|
2000-11-30 |
2016-09-05 |
Vectura Ltd |
Process for preparing particles for use in a pharmaceutical composition
|
ATE446085T1
(de)
|
2000-11-30 |
2009-11-15 |
Vectura Ltd |
Partikel zur verwendung in einer pharmazeutischen zusammensetzung
|
EP1241110A1
(en)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Dispensing unit for oxygen-sensitive drugs
|
EP1243524A3
(en)
|
2001-03-16 |
2004-04-07 |
Pfizer Products Inc. |
Pharmaceutical kit for oxygen-sensitive drugs
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
DE10126924A1
(de)
|
2001-06-01 |
2002-12-05 |
Boehringer Ingelheim Pharma |
Inhalationskapseln
|
EP1425001B1
(en)
|
2001-09-14 |
2008-12-17 |
Glaxo Group Limited |
Phenethanolamine derivatives for treatment of respiratory diseases
|
US8777011B2
(en)
|
2001-12-21 |
2014-07-15 |
Novartis Ag |
Capsule package with moisture barrier
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
US20030203141A1
(en)
|
2002-04-25 |
2003-10-30 |
Blum John B. |
Blister package
|
US8003179B2
(en)
|
2002-06-20 |
2011-08-23 |
Alcan Packaging Flexible France |
Films having a desiccant material incorporated therein and methods of use and manufacture
|
US20040131805A1
(en)
|
2002-06-20 |
2004-07-08 |
Merical Rick L. |
Films having a desiccant material incorporated therein and methods of use and manufacture
|
US20030235664A1
(en)
|
2002-06-20 |
2003-12-25 |
Rick Merical |
Films having a desiccant material incorporated therein and methods of use and manufacture
|
US20060269708A1
(en)
|
2002-06-20 |
2006-11-30 |
Rick Merical |
Films having a desiccant material incorporated therein and methods of use and manufacture
|
US20060236868A1
(en)
|
2003-05-19 |
2006-10-26 |
Bester Pansegrouw |
Dessicant container
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
SE527191C2
(sv)
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av tiotropium och fluticason
|
GB0315889D0
(en)
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
EP1641437A4
(en)
|
2003-07-09 |
2009-06-03 |
Chong Kun Dang Pharm Corp |
SOLID DISPERSION OF TACROLIMUS
|
GB0316341D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
EP1643973A1
(en)
*
|
2003-07-11 |
2006-04-12 |
Glaxo Group Limited |
Pharmaceutical formulations comprising magnesium stearate
|
US20050072958A1
(en)
|
2003-10-02 |
2005-04-07 |
Thomas Powers |
Oxygen scavenger for low moisture environment and methods of using the same
|
CN1893948A
(zh)
|
2003-10-14 |
2007-01-10 |
葛兰素集团有限公司 |
蕈毒碱性乙酰胆碱受体拮抗剂
|
WO2005044186A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
|
GB0326632D0
(en)
*
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
SE0303269L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Medicinsk produkt
|
SE0303270L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
AU2004294889B2
(en)
|
2003-12-03 |
2010-08-26 |
Boehringer Ingelheim International Gmbh |
Medical product containing tiotropium
|
SE0303569L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
DPI för avlämning av fuktkänsliga medikament
|
BRPI0417097A
(pt)
|
2003-12-03 |
2007-03-13 |
Microdrug Ag |
inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade
|
SE0303570L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
GB2410192B
(en)
|
2004-01-23 |
2005-12-07 |
Eg Technology Ltd |
An inhaler
|
AR050902A1
(es)
|
2004-04-27 |
2006-12-06 |
Glaxo Group Ltd |
Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
|
GB0409703D0
(en)
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
EP1761279A1
(en)
|
2004-05-31 |
2007-03-14 |
Laboratorios Almirall, S.A. |
Combinations comprising antimuscarinic agents and pde4 inhibitors
|
SE530006C2
(sv)
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
SE0401654D0
(sv)
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
GB0416397D0
(en)
|
2004-07-22 |
2004-08-25 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
JP2008510014A
(ja)
|
2004-08-16 |
2008-04-03 |
セラヴァンス, インコーポレーテッド |
β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
|
KR20070072603A
(ko)
|
2004-10-21 |
2007-07-04 |
베링거 인겔하임 인터내셔날 게엠베하 |
흡입기용 블리스터
|
US7501011B2
(en)
|
2004-11-09 |
2009-03-10 |
Multisorb Technologies, Inc. |
Humidity control device
|
SE0402976L
(sv)
|
2004-12-03 |
2006-06-04 |
Mederio Ag |
Medicinsk produkt
|
PE20061162A1
(es)
|
2004-12-06 |
2006-10-14 |
Smithkline Beecham Corp |
Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
|
PE20060826A1
(es)
|
2004-12-06 |
2006-10-08 |
Smithkline Beecham Corp |
Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
|
US7938580B2
(en)
|
2004-12-08 |
2011-05-10 |
Perfecseal, Inc. |
Sterilizable package with a high barrier to oxygen
|
US20060183804A1
(en)
|
2004-12-27 |
2006-08-17 |
Brinkman Kyle R |
Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions
|
US20060144733A1
(en)
|
2004-12-30 |
2006-07-06 |
3M Innovative Properties Company |
Container assembly and method for humidity control
|
WO2006086130A2
(en)
|
2005-02-10 |
2006-08-17 |
Glaxo Group Limited |
Process for crystallizing lactose particles for use in pharmaceutical formulations
|
BRPI0606364A2
(pt)
|
2005-02-10 |
2010-03-23 |
Glaxo Group Ltd |
processo para formar lactose adequada para uso em uma formulaÇço farmacÊutica
|
DE202005002409U1
(de)
|
2005-02-15 |
2005-07-07 |
Microdrug Ag |
Inhalierbares Tiotropium und Behälter dafür
|
DE202005004659U1
(de)
|
2005-03-22 |
2005-07-07 |
Microdrug Ag |
Vordosierter Trockenpulverinhalator für feuchtigkeitsempfindliche Medikamente
|
GB0507165D0
(en)
|
2005-04-08 |
2005-05-18 |
Glaxo Group Ltd |
Novel crystalline pharmaceutical product
|
JP4659523B2
(ja)
|
2005-04-26 |
2011-03-30 |
共同印刷株式会社 |
ブリスター用フィルム及びブリスター用包装容器
|
WO2006124556A2
(en)
|
2005-05-13 |
2006-11-23 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
DE102005022862A1
(de)
|
2005-05-18 |
2006-12-14 |
Airsec S.A.S |
Kapseln für Inhalatoren
|
GB0523653D0
(en)
*
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
US20060278965A1
(en)
|
2005-06-10 |
2006-12-14 |
Foust Donald F |
Hermetically sealed package and methods of making the same
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
CA2623658A1
(en)
|
2005-09-28 |
2007-04-05 |
Mederio Ag |
Inhaler device for moisture sensitive drugs and method of operating an inhaler device
|
GB0520794D0
(en)
|
2005-10-12 |
2005-11-23 |
Innovata Biomed Ltd |
Inhaler
|
EP1780005B1
(de)
|
2005-10-18 |
2009-03-11 |
Alcan Technology & Management Ltd. |
Kaltverformbares Laminat für Blisterbodenteile
|
EP1787800A1
(de)
|
2005-11-17 |
2007-05-23 |
Alcan Technology & Management Ltd. |
Kaltverformbares Laminat für Blisterbodenteile
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
US20090012132A1
(en)
|
2006-02-27 |
2009-01-08 |
Takeda Pharmaceutical Company Limited |
Pharmaceutical Package
|
KR100764640B1
(ko)
|
2006-03-08 |
2007-10-10 |
세원셀론텍(주) |
지방조직 수복용 키트
|
WO2007109606A2
(en)
|
2006-03-17 |
2007-09-27 |
Csp Technologies, Inc. |
Moisture-tight primary packaging for a dry powder inhaler
|
WO2007117911A2
(en)
|
2006-03-22 |
2007-10-18 |
3M Innovative Properties Company |
Novel formulations
|
MX2008011967A
(es)
|
2006-03-22 |
2009-01-14 |
Glaxo Group Ltd |
Formulaciones novedosas.
|
CA2644423A1
(en)
|
2006-03-24 |
2007-10-04 |
Ian Simon Tracton |
Stable packaged dosage form and process therefor
|
JP2010526763A
(ja)
|
2006-05-24 |
2010-08-05 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系疾患を治療するための新規な長時間作用型の薬剤組成物
|
GB0615108D0
(en)
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel formulations
|
RU2448026C2
(ru)
|
2006-08-03 |
2012-04-20 |
Мерк Патент Гмбх |
Упаковка, содержащая фармацевтические лекарственные формы
|
WO2008021142A2
(en)
|
2006-08-09 |
2008-02-21 |
Glaxo Group Limited |
Process for manufacturing lactose
|
US20090298742A1
(en)
|
2006-08-09 |
2009-12-03 |
Glaxo Group Limited |
Process for manufacturing lactose
|
FI20065636A0
(fi)
|
2006-10-04 |
2006-10-04 |
Lab Pharma Ltd |
Dessikanttijärjestelmä irtohaloitavien jauheiden kosteuden säätämiseksi
|
JP2010507617A
(ja)
|
2006-10-26 |
2010-03-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系及び消化器系障害の治療用の新規な医薬組成物
|
US20080178559A1
(en)
|
2007-01-26 |
2008-07-31 |
Multisorb Technologies, Inc. |
Sorbent Packaging
|
MY158271A
(en)
|
2007-03-29 |
2016-09-30 |
Multisorb Tech Inc |
Method for selecting adsorptive composite barriers for packaging applications
|
US7549272B2
(en)
|
2007-04-16 |
2009-06-23 |
Multisorb Technologies, Inc. |
Sorbent canister with beveled edges
|
WO2008135570A1
(en)
|
2007-05-07 |
2008-11-13 |
Airsec |
Container with moisture control capacity
|
UY31233A1
(es)
|
2007-07-21 |
2009-03-02 |
|
Unidades de envasado con un agente desecante
|
PE20090907A1
(es)
|
2007-07-21 |
2009-08-05 |
Boehringer Ingelheim Int |
Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
|
WO2009029029A1
(en)
|
2007-08-24 |
2009-03-05 |
Astrazeneca Ab |
Inhaler for powdered substances with desiccant compartment
|
EP2197444A1
(en)
|
2007-09-12 |
2010-06-23 |
Glaxo Group Limited |
Novel combination of therapeutic agents
|
EP2080523A1
(en)
|
2008-01-15 |
2009-07-22 |
CHIESI FARMACEUTICI S.p.A. |
Compositions comprising an antimuscarinic and a long-acting beta-agonist
|
WO2009103336A1
(de)
|
2008-02-20 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Pulverinhalatoren
|
JP4983657B2
(ja)
|
2008-03-11 |
2012-07-25 |
富士通株式会社 |
電子メール管理プログラム、該プログラムを記録した記録媒体、通信端末、および電子メール管理方法
|
EP2127628A1
(en)
|
2008-05-27 |
2009-12-02 |
Ranbaxy Laboratories Limited |
Unit dose pack
|
US9095324B2
(en)
|
2008-06-20 |
2015-08-04 |
Boston Scientific Scimed, Inc. |
Package assembly
|
EP2350049B1
(en)
|
2008-10-02 |
2014-02-26 |
Respivert Limited |
P38 map kinase inhibitors
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
WO2010097114A1
(en)
*
|
2009-02-26 |
2010-09-02 |
Glaxo Group Limited |
Novel combination of therapeutic agents
|
LT2400950T
(lt)
*
|
2009-02-26 |
2019-08-26 |
Glaxo Group Limited |
Farmacinės kompozicijos, apimančios 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzil)oksi]etoksi}heksil)amino]-1-hidroksetil}-2-(hidroksimetil)fenolį
|
BRPI1009072B1
(pt)
|
2009-05-18 |
2021-06-22 |
Adamis Pharmaceuticals Corporation |
Dispositivo para inalação de pó seco e dispositivo para armazenamento de pó seco
|
ATE546386T1
(de)
|
2009-07-23 |
2012-03-15 |
Airsec Sas |
Hydrierte feuchtigkeitskontrollsubstanz und herstellungsverfahren dafür
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
BR112013031572A2
(pt)
|
2011-06-08 |
2017-03-21 |
Glaxo Group Ltd |
produto de combinação farmacêutica, e, inalador de pó seco.
|
RU2013153202A
(ru)
|
2011-06-08 |
2015-07-20 |
Глаксо Груп Лимитед |
Композиции для ингалятора сухого порошка, содержащие умеклидиний
|
GB201222679D0
(en)
|
2012-12-17 |
2013-01-30 |
Glaxo Group Ltd |
Pharmaceutical combination products
|